Want to join the conversation?
Life science technology company $VIVO said that it acquired Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. The company expects Magellan to contribute to EPS during calendar 2H17. $VIVO will finance the purchase price of $66MM using a combination of cash on hand and a $60MM five-year term loan.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.